1. Home
  2. CCEL vs CLST Comparison

CCEL vs CLST Comparison

Compare CCEL & CLST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCEL
  • CLST
  • Stock Information
  • Founded
  • CCEL 1989
  • CLST 1922
  • Country
  • CCEL United States
  • CLST United States
  • Employees
  • CCEL N/A
  • CLST N/A
  • Industry
  • CCEL Managed Health Care
  • CLST
  • Sector
  • CCEL Health Care
  • CLST
  • Exchange
  • CCEL Nasdaq
  • CLST Nasdaq
  • Market Cap
  • CCEL 53.9M
  • CLST 52.2M
  • IPO Year
  • CCEL 1997
  • CLST N/A
  • Fundamental
  • Price
  • CCEL $6.36
  • CLST $11.39
  • Analyst Decision
  • CCEL
  • CLST
  • Analyst Count
  • CCEL 0
  • CLST 0
  • Target Price
  • CCEL N/A
  • CLST N/A
  • AVG Volume (30 Days)
  • CCEL 3.5K
  • CLST 11.2K
  • Earning Date
  • CCEL 10-18-2024
  • CLST 10-24-2024
  • Dividend Yield
  • CCEL N/A
  • CLST N/A
  • EPS Growth
  • CCEL N/A
  • CLST N/A
  • EPS
  • CCEL N/A
  • CLST N/A
  • Revenue
  • CCEL $31,641,636.00
  • CLST $4,388,000.00
  • Revenue This Year
  • CCEL $3.70
  • CLST N/A
  • Revenue Next Year
  • CCEL $10.57
  • CLST N/A
  • P/E Ratio
  • CCEL N/A
  • CLST N/A
  • Revenue Growth
  • CCEL 1.93
  • CLST N/A
  • 52 Week Low
  • CCEL $3.67
  • CLST $10.60
  • 52 Week High
  • CCEL $9.50
  • CLST $12.10
  • Technical
  • Relative Strength Index (RSI)
  • CCEL 47.46
  • CLST 53.16
  • Support Level
  • CCEL $6.16
  • CLST $11.30
  • Resistance Level
  • CCEL $7.19
  • CLST $11.46
  • Average True Range (ATR)
  • CCEL 0.30
  • CLST 0.20
  • MACD
  • CCEL 0.02
  • CLST 0.06
  • Stochastic Oscillator
  • CCEL 19.53
  • CLST 74.68

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.

About CLST Catalyst Bancorp Inc.

Catalyst Bancorp Inc is a federally chartered community-oriented savings bank. The bank is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources which are used for the origination of loans. The Bank derives its income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.

Share on Social Networks: